New Drug Targets Tau in Alzheimer's | Irvine News

Presented by The Plant Daddies — rare specimen trees, living art, and hand-carved limestone vessels and fountains for extraordinary spaces. Showrooms in Los Angeles and Irvine. Listeners of Irvine News Today receive 10% off with code LANEWS10. theplantdaddies.com/lanews A breakthrough in Alzheimer’s research shines a new light on tau: an experimental drug called diranersen, delivered via spinal injection, slashes tau production at its source—without targeting amyloid. Unlike current treatments, this antisense oligonucleotide gently tells genes to make less tau, letting the brain’s cleanup crew do their job. Early results from Biogen’s trial—even the lowest dose every six months—showed the strongest tau reduction, sparking cautious optimism. Experts hope this could revive investment in tau therapies, while other avenues like tau vaccines and heart drugs also advance. The race to beat Alzheimer’s is accelerating, and this could be a pivotal step. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a06c0d32831438d7